
Christopher P. Jones
Examiner (ID: 5555, Phone: (571)270-7383 , Office: P/1776 )
| Most Active Art Unit | 1776 |
| Art Unit(s) | 1776, 1797 |
| Total Applications | 1840 |
| Issued Applications | 1378 |
| Pending Applications | 121 |
| Abandoned Applications | 373 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14864875
[patent_doc_number] => 20190282679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => TOXOPLASMA GONDII VACCINES AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/094394
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094394
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094394 | TOXOPLASMA GONDII VACCINES AND THEIR USE | Apr 13, 2017 | Abandoned |
Array
(
[id] => 11992482
[patent_doc_number] => 20170296637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'Chagas Antigens and Antibodies and Compositions, Methods and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/487935
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 33524
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15487935
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/487935 | Chagas antigens and antibodies and compositions, methods and uses thereof | Apr 13, 2017 | Issued |
Array
(
[id] => 16170785
[patent_doc_number] => 10712341
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Biosensor
[patent_app_type] => utility
[patent_app_number] => 15/487665
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 13595
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15487665
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/487665 | Biosensor | Apr 13, 2017 | Issued |
Array
(
[id] => 14216907
[patent_doc_number] => 20190120838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => METHODS AND KITS FOR THE RAPID DETECTION OF THE ESCHERICHIA COLI O25B-ST131 CLONE
[patent_app_type] => utility
[patent_app_number] => 16/093202
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093202
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093202 | METHODS AND KITS FOR THE RAPID DETECTION OF THE ESCHERICHIA COLI O25B-ST131 CLONE | Apr 11, 2017 | Abandoned |
Array
(
[id] => 11977589
[patent_doc_number] => 20170281740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'SERODIAGNOSIS OF SALMON POISONING DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/476011
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 37553
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476011
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/476011 | SERODIAGNOSIS OF SALMON POISONING DISEASE | Mar 30, 2017 | Abandoned |
Array
(
[id] => 14306425
[patent_doc_number] => 20190142916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => BIOMARKERS AND IMMUNOGENIC COMPOSITIONS FOR FILARIAL PARASITES
[patent_app_type] => utility
[patent_app_number] => 16/090013
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15662
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090013
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090013 | BIOMARKERS AND IMMUNOGENIC COMPOSITIONS FOR FILARIAL PARASITES | Mar 30, 2017 | Abandoned |
Array
(
[id] => 11864806
[patent_doc_number] => 20170232091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'NOVEL ANTIGEN FOR USE IN MALARIA'
[patent_app_type] => utility
[patent_app_number] => 15/431609
[patent_app_country] => US
[patent_app_date] => 2017-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9666
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15431609
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/431609 | Antigen for use in malaria | Feb 12, 2017 | Issued |
Array
(
[id] => 11647914
[patent_doc_number] => 20170143814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'IMMUNOTHERAPY USING CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES'
[patent_app_type] => utility
[patent_app_number] => 15/421758
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 74088
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15421758
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/421758 | IMMUNOTHERAPY USING CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES | Jan 31, 2017 | Abandoned |
Array
(
[id] => 17043841
[patent_doc_number] => 11097001
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-08-24
[patent_title] => Composition and method against tuberculosis
[patent_app_type] => utility
[patent_app_number] => 15/421689
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6650
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15421689
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/421689 | Composition and method against tuberculosis | Jan 31, 2017 | Issued |
Array
(
[id] => 19624109
[patent_doc_number] => 12162913
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/074289
[patent_app_country] => US
[patent_app_date] => 2017-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 19
[patent_no_of_words] => 24588
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074289
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074289 | None | Jan 24, 2017 | Issued |
Array
(
[id] => 16369096
[patent_doc_number] => 10800837
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-13
[patent_title] => Immunotherapies employing self-assembling vaccines
[patent_app_type] => utility
[patent_app_number] => 15/369298
[patent_app_country] => US
[patent_app_date] => 2016-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 21
[patent_no_of_words] => 20025
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15369298
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/369298 | Immunotherapies employing self-assembling vaccines | Dec 4, 2016 | Issued |
Array
(
[id] => 11567384
[patent_doc_number] => 20170106028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'AGENT FOR INDUCING INTERFERON PRODUCTION CONTAINING LACTIC ACID BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 15/367649
[patent_app_country] => US
[patent_app_date] => 2016-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 14395
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15367649
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/367649 | Agent for inducing interferon production containing lactic acid bacteria | Dec 1, 2016 | Issued |
Array
(
[id] => 11647873
[patent_doc_number] => 20170143774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'COMPOSITIONS COMPRISING BACTERIAL STRAINS'
[patent_app_type] => utility
[patent_app_number] => 15/359972
[patent_app_country] => US
[patent_app_date] => 2016-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16778
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15359972
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/359972 | Compositions comprising bacterial strains | Nov 22, 2016 | Issued |
Array
(
[id] => 12724402
[patent_doc_number] => 20180133301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => IMMUNOGENIC AND VACCINE COMPOSITIONS FOR USE AGAINST BORDETELLA BRONCHISEPTICA INFECTION
[patent_app_type] => utility
[patent_app_number] => 15/354964
[patent_app_country] => US
[patent_app_date] => 2016-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15354964
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/354964 | IMMUNOGENIC AND VACCINE COMPOSITIONS FOR USE AGAINST BORDETELLA BRONCHISEPTICA INFECTION | Nov 16, 2016 | Abandoned |
Array
(
[id] => 11469706
[patent_doc_number] => 20170056490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-02
[patent_title] => 'IMMUNOGENIC COMPOSITION FOR USE IN THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/351847
[patent_app_country] => US
[patent_app_date] => 2016-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12104
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15351847
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/351847 | IMMUNOGENIC COMPOSITION FOR USE IN THERAPY | Nov 14, 2016 | Abandoned |
Array
(
[id] => 17207772
[patent_doc_number] => 11168131
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-09
[patent_title] => Antibody molecule-drug conjugates and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/348436
[patent_app_country] => US
[patent_app_date] => 2016-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 27
[patent_no_of_words] => 71737
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15348436
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/348436 | Antibody molecule-drug conjugates and uses thereof | Nov 9, 2016 | Issued |
Array
(
[id] => 13519567
[patent_doc_number] => 20180311326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => IMMUNOASSEMBLIN (IA) PROTEIN COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 15/771837
[patent_app_country] => US
[patent_app_date] => 2016-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15771837
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/771837 | IMMUNOASSEMBLIN (IA) PROTEIN COMPLEXES | Nov 8, 2016 | Abandoned |
| 15/345945 | BURKHOLDERIA PSEUDOMALLEI COMPOSITION/VACCINE | Nov 7, 2016 | |
Array
(
[id] => 11543524
[patent_doc_number] => 20170097349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'DIAGNOSTIC REAGENTS'
[patent_app_type] => utility
[patent_app_number] => 15/343522
[patent_app_country] => US
[patent_app_date] => 2016-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7540
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15343522
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/343522 | Diagnostic reagents | Nov 3, 2016 | Issued |
Array
(
[id] => 14043489
[patent_doc_number] => 20190077851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => METHODS OF USING ANTI-ALPHA TOXIN ANTIBODY
[patent_app_type] => utility
[patent_app_number] => 15/769221
[patent_app_country] => US
[patent_app_date] => 2016-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23024
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15769221
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/769221 | METHODS OF USING ANTI-ALPHA TOXIN ANTIBODY | Oct 26, 2016 | Abandoned |